Cargando…
Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective
SIMPLE SUMMARY: Surgical resection is the standard of care for malignant adnexal cancers of the skin. The efficacy of radiotherapy and targeted therapies is still undetermined in both adjuvant and palliative settings. In routine clinical practice, genetic abnormalities are rarely assessed, although...
Autores principales: | Kleibert, Marcin, Płachta, Iga, Czarnecka, Anna M., Spałek, Mateusz J., Szumera-Ciećkiewicz, Anna, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870474/ https://www.ncbi.nlm.nih.gov/pubmed/35205753 http://dx.doi.org/10.3390/cancers14040998 |
Ejemplares similares
-
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation
por: Płachta, Iga, et al.
Publicado: (2021) -
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation
por: Płachta, Iga, et al.
Publicado: (2021) -
Mutation profile of primary subungual melanomas in Caucasians
por: Borkowska, Aneta, et al.
Publicado: (2020) -
Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021) -
Epithelioid Sarcoma—From Genetics to Clinical Practice
por: Czarnecka, Anna M., et al.
Publicado: (2020)